Healthcare Sector

GILD

Market Tracker

$121.00
+0.26
(+0.22%)
1:20 pm
Next Earnings: (est.) 08/02/23 12:00 am
  • GILD (Selected)

    Gilead Sciences, Inc.

GILD Support / Resistance Levels

Loading Data..
WhaleStream

15m Chart - Support and Resistance levels are based on the large dark pool & equity prints at the plotted levels. Displays strongest levels above and below the spot price.

GILD Most Active Options Strike Prices Whale BUY Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.

GILD Most Active Options Strike Prices Whale SALES Activity - 5 day

Loading Data..

Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.

GILD Dark Pool and Public Equity Key Price Levels

Loading Data..

Represents the largest cumulative premium levels above and below the current spot price. The price in the pink bubble represents the spot price.

GILD Open Interest Trend

Loading Data..

Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.

GILD Largest 1-Day Open Interest Movements

Expires Type Strike OI Change Percent
10/24/2025 PUT $119.00 3,807 +3,718 +4,177.53%
10/24/2025 CALL $122.00 3,567 +1,976 +124.20%
10/24/2025 PUT $117.00 1,038 +734 +241.45%
10/24/2025 CALL $123.00 855 +326 +61.63%
01/16/2026 CALL $130.00 1,927 +298 +18.29%
01/16/2026 PUT $120.00 250 +250
11/07/2025 CALL $130.00 3,583 -14 -0.39%
10/24/2025 PUT $124.00 87 -21 -19.44%
01/16/2026 CALL $115.00 2,715 -24 -0.88%
11/07/2025 PUT $115.00 3,536 -28 -0.79%
10/24/2025 CALL $125.00 996 -37 -3.58%
11/21/2025 CALL $120.00 3,620 -140 -3.72%

Contracts with largest changes in open interest from the previous trading day to the current/most recent.

GILD Major Holders

Name Pct Held Shares Total
Vanguard Total Stock Market Index Fund 3.05% 38.12M 2.91B
Income Fund of America Inc 2.70% 33.74M 2.58B
Vanguard 500 Index Fund 2.32% 28.99M 2.21B
Dodge & Cox Stock Fund 2.02% 25.19M 1.92B
Washington Mutual Investors Fund 1.57% 19.64M 1.5B
American Balanced Fund 1.37% 17.14M 1.31B
American Mutual Fund Inc 1.33% 16.67M 1.27B
Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF 1.31% 16.4M 1.25B
Fidelity 500 Index Fund 1.10% 13.75M 1.05B
SPDR S&P 500 ETF Trust 1.08% 13.5M 1.03B

GILD News

  • Nurix Initiates DAYBreak™ Pivotal Study of Bexobrutideg in Relapsed or Refractory Chronic Lymphocytic Leukemia

    10/22 06:00 am

    GlobeNewswire Inc.

    Read more
  • Galapagos kondigt intentie aan om celtherapieactiviteiten af te bouwen als onderdeel van de voortdurende transformatie van het bedrijf

    10/21 01:30 am

    GlobeNewswire Inc.

    Read more
  • Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation

    10/21 01:30 am

    GlobeNewswire Inc.

    Read more
  • NCBCP Celebrates President & CEO, Melanie L. Campbell's 30 Years of Leadership and Service During the 28th Annual Spirit of Democracy Awards Gala

    10/20 03:45 pm

    Benzinga

    Read more
  • Nurix Therapeutics Reports New Clinical Data from First-in-Class Oral CBL-B Inhibitor, NX-1607, Demonstrating Single-Agent Activity Across Multiple Tumor Types at the European Society for Medical Oncology (ESMO) Congress

    10/18 03:00 am

    GlobeNewswire Inc.

    Read more
  • UK Health Agency Recommends GSK-Backed ViiV Healthcare's Apretude As Injectable HIV Treatment

    10/17 12:43 pm

    Benzinga

    Read more
  • Merck's New HIV Treatment Works As Well As Top Drug In Late Trials

    10/15 12:23 pm

    Benzinga

    Read more
  • Multiple Myeloma CAR-T Market Set for Rapid Growth Driven by BCMA-Targeted Therapies and Innovative Advances

    10/08 11:00 am

    GlobeNewswire Inc.

    Read more
  • Gene Therapy Market Size to Worth USD 58.87 Billion Rising at 20% CAGR by 2034 | Towards Healthcare

    10/08 10:00 am

    GlobeNewswire Inc.

    Read more
  • Immatics Appoints Venkat Ramanan as Chief Financial Officer

    10/01 07:00 am

    GlobeNewswire Inc.

    Read more
  • Top Security Executives Recognized at the 2025 BayAreaCISO ORBIE Awards

    09/25 03:49 pm

    GlobeNewswire Inc.

    Read more
  • Fangzhou Named ‘Outstanding Growth Story in Hong Kong Stocks’ at China Capital Market Development Forum 2025

    09/17 10:44 pm

    GlobeNewswire Inc.

    Read more
  • Biotech Sector May Flip to Market Leader by Year-End

    09/15 01:25 pm

    Investing.com

    Read more
  • Australia Acute Respiratory Distress Syndrome Market Growth and Company Report 2025-2033 Featuring Silence Therapeutics, Gilead Sciences, Terumo, Getinge, Livanova, Medtronic, Fresenius, Nipro, Pfizer

    09/04 11:00 am

    GlobeNewswire Inc.

    Read more
  • Pharming Group appoints Kenneth Lynard as Chief Financial Officer

    09/02 01:00 am

    GlobeNewswire Inc.

    Read more
  • Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy

    08/21 11:45 am

    Benzinga

    Read more
  • Ligand to Participate in September Investor Conferences

    08/19 04:00 pm

    GlobeNewswire Inc.

    Read more
  • MacroGenics Revenue Doubles in Q2

    08/14 04:21 pm

    The Motley Fool

    Read more
  • Kymera Revenue Drops 55 Percent in Q2

    08/11 07:28 am

    The Motley Fool

    Read more
  • Tango (TNGX) Q2 Revenue Drops 52%

    08/05 08:25 pm

    The Motley Fool

    Read more
  • IDEAYA (IDYA) Q2 Net Loss Improves 27%

    08/05 04:23 pm

    The Motley Fool

    Read more
  • MCL1 Inhibitor Drugs Clinical Trials & Market Opportunity Report 2025: Over 12 ML1 Inhibitor Drugs In Clinical Trials

    08/05 04:28 am

    GlobeNewswire Inc.

    Read more
  • Gilead's Newly Approved HIV Prevention Drug Poised To Add Billions To Future Sales

    07/25 12:12 pm

    Benzinga

    Read more
  • INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD

    07/06 10:00 am

    GlobeNewswire Inc.

    Read more
  • Why Gilead Scinces Stock Tumbled on Tuesday

    06/10 05:22 pm

    The Motley Fool

    Read more
  • 2 Stocks, 100%+ Combined Gains - All From Spotting Mispricing Before the Crowd

    06/08 03:45 am

    Investing.com

    Read more
  • Nurix Therapeutics to Host a Webcast Conference Call to Discuss Data from the Ongoing Phase 1 Clinical Trial of Bexobrutideg (NX-5948) Being Presented at the 30th European Hematology Association Congress (EHA2025)

    06/06 07:00 am

    GlobeNewswire Inc.

    Read more
  • Xilio Therapeutics Announces Closing of $50.0 Million Public Offering

    06/05 06:38 pm

    GlobeNewswire Inc.

    Read more
  • Merus annonce ses résultats financiers pour le premier trimestre 2025 et fait le point sur ses activités

    05/09 10:46 am

    GlobeNewswire Inc.

    Read more
  • Nurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel Drugs

    04/28 04:00 pm

    GlobeNewswire Inc.

    Read more
  • Gilead Cancer Drug Combined With Merck's Drug Effective In Difficult To Treat Type Of Breast Cancer

    04/21 02:49 pm

    Benzinga

    Read more
  • 2 High-Yielding ETFs Retirees Can Safely Build Their Portfolios Around

    04/17 05:45 am

    The Motley Fool

    Read more
  • 2 Top Dividend Stocks That Could Set You Up for Life

    04/09 07:00 am

    The Motley Fool

    Read more
  • Is Vertex Pharmaceuticals Stock a Buy?

    04/08 09:45 am

    The Motley Fool

    Read more
  • Minimal Residual Disease Testing Market Forecast Report, 2025-2030 - Precision Medicine and Early Relapse Detection Drive MRD Testing Demand Worldwide

    04/08 04:48 am

    GlobeNewswire Inc.

    Read more
  • 3 Stocks Leading Healthcare’s Comeback as Wall Street Turns Defensive

    04/02 12:14 pm

    Investing.com

    Read more
  • Pharmaceutical Firms Say UK Investment Is 'Unlikely' Unless Payment Levy Is Adressed

    03/21 12:31 pm

    Benzinga

    Read more
  • Bispecific Antibody Market Opportunity, Drug Dosage, Patent, Price, Sales & Clinical Trials Insight 2030: New Report Highlights 600+ Bispecific Antibodies in Clinical Trials Worldwide

    03/12 08:48 am

    GlobeNewswire Inc.

    Read more
  • The Top Nasdaq-100 Stock in 2025 Has Nothing to Do With Artificial Intelligence (AI)

    03/11 04:20 am

    The Motley Fool

    Read more
  • Non-Small Cell Lung Cancer Market Set for Significant Growth Across the 7MM During the Study Period (2025-2034) Due to the Rising Novel Therapeutic Options | DelveInsight

    02/26 02:00 pm

    GlobeNewswire Inc.

    Read more
  • Questex’s Fierce Pharma Unveils the Conference Program for the Inaugural Fierce Pharma Engage, Over 100 Speakers Confirmed to Deliver Unparalleled Education

    02/24 11:00 am

    GlobeNewswire Inc.

    Read more
  • Why Gilead Sciences Stock Is Jumping Today

    02/12 01:21 pm

    The Motley Fool

    Read more
  • Gilead Sciences Beats Q4 EPS Forecast

    02/11 05:40 pm

    The Motley Fool

    Read more
  • 3 Fabulous Dividend Stocks to Buy in February

    02/09 03:30 pm

    The Motley Fool

    Read more
  • These 2 Dividend Stocks Are Absolute Bargains Right Now

    02/08 09:30 am

    The Motley Fool

    Read more
  • 3 Top AI-Powered Biotech Stocks to Buy in February

    02/06 10:45 am

    The Motley Fool

    Read more
  • Global Pharma & Biotech CRM Software Market To Surpass Valuation of US$ 20.0 Billion by 2033 | Astute Analytica

    01/17 04:30 am

    GlobeNewswire Inc.

    Read more
👀

Follow the Whales in real-time.

🎁

Take 50% OFF With Code: